Read + Share
Amedeo Smart
Independent Medical Education
Xie C, Hang Y, Zhu J, Li C, et al. Benefit and risk of adding rivaroxaban in patients with coronary artery disease: A systematic review and meta-analysis. Clin Cardiol 2020 Nov 21. doi: 10.1002/clc.23514.PMID: 33219708
Email
LinkedIn
Facebook
Twitter
Privacy Policy